Cristina Gutiérrez Miguélez

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial

Vratislav Strnad, Oliver J. Ott, Guido Hildebrandt et al. · The Lancet · 2015 · 656 citations

Medicine, Oncology, Radiation Oncology +16

Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial

Csaba Polgár, Oliver J. Ott, Guido Hildebrandt et al. · The Lancet Oncology · 2017 · 255 citations

Medicine, Oncology, Radiation Oncology +17

Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network

Aurelius Omlin, Maurizio Amichetti, D. Azria et al. · The Lancet Oncology · 2006 · 137 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial

Rebekka Schäfer, Vratislav Strnad, Csaba Polgár et al. · The Lancet Oncology · 2018 · 122 citations

Medicine, Oncology, Radiation Oncology +15

GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance

Oliver J. Ott, Vratislav Strnad, Guido Hildebrandt et al. · Radiotherapy and Oncology · 2016 · 111 citations

Medicine, Oncology, Radiation Oncology +17